BioCentury
ARTICLE | Financial News

1315 Capital closes $200M first fund

June 17, 2016 12:32 AM UTC

1315 Capital closed its first fund at $200 million. The Philadelphia-based firm plans to invest in commercial-stage companies including specialty pharmaceutical, medtech and healthcare services compan...